How much funding has Apogee Therapeutics raised?

Apogee Therapeutics has raised $169.0M in total funding, most recently a Series B round.

Who are Apogee Therapeutics's investors?

Apogee Therapeutics's investors include Deep Track Capital, RTW Investments.

When was Apogee Therapeutics founded?

Apogee Therapeutics was founded in 2022.

Where is Apogee Therapeutics headquartered?

Apogee Therapeutics is headquartered in South San Francisco, California, United States.

What industry is Apogee Therapeutics in?

Apogee Therapeutics operates in Biotech, Healthcare.

How many employees does Apogee Therapeutics have?

Apogee Therapeutics has 51-200 employees.

Apogee Therapeutics

IPO

Best-in-Class Therapies for Immunological and Inflammatory Disorders

Public · South San Francisco, United States · Founded 2022 · $169.0M raised

Biotech

Healthcare

Headquarters: South San Francisco, California
Employees: 51–200
Founded: 2022
Business Model: B2B
Website: apogeetherapeutics.com

Total Funding: $169.0M
Last Round: $149.0M Series BDec 2022
Rounds: 2
Type: Public

About

Apogee Therapeutics is a clinical-stage biotechnology company developing novel antibody therapeutics for inflammatory and immune diseases, including atopic dermatitis, asthma, and eosinophilic esophagitis. Founded 2022 and headquartered in South San Francisco, the company's lead program zumilokibart (APG777) targets IL-13 and is in Phase 2 trials.

Summary

Apogee Therapeutics is a Biotech company based in South San Francisco, United States, founded in 2022. It has raised $169.0M in total across 2 rounds, most recently a $149.0M Series B round in Dec 2022. Investors include Deep Track Capital and RTW Investments.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOJul 2023

$300.0M

Jul 2023

Sign up to see all 3 rounds

Series A through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Deep Track Capital

Lead

1 round

RTW Investments

Lead

1 round

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare

Growth Equity·$5.1B·Aug 2022

IVI-RMA

IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...

Valencia, Spain5001–10000Biotech, Healthcare

Private Equity·$3.3B·Apr 2022

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech

Series A·$3.0B·Jan 2022

inVentiv HealthAcquired

inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...

Burlington, United States5001–10000Biotech, Healthcare

Private Equity·$3.0B·May 2017

Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare

Private Equity·$3.0B·Jan 2004

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology

Corporate Round·$2.8B·Jan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

<a href="https://indexed.vc/companies/apogee-therapeutics"><img src="https://indexed.vc/api/badge/company/apogee-therapeutics" alt="Apogee Therapeutics on Indexed.vc" width="260" height="76" /></a>